Neutrophils Response to Human CMV Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients

被引：0
|
作者：
Costa, Martina [1 ]
Tamassia, Nicola [1 ]
Ligozzi, Marco [1 ]
Marini, Olivia [1 ]
Cassatella, Marco [1 ]
Tecchio, Cristina [1 ]
机构：
[1] Univ Verona, Verona, Italy
来源：
BONE MARROW TRANSPLANTATION | 2020年 / 55卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P392
引用
下载
收藏
页码：479 / 479
页数：1
相关论文
共 50 条
  • [41] Coadministration of posaconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients
    R Greco
    M C Barbanti
    MT Lupo Stranghellini
    F Giglio
    M Morelli
    C Messina
    A Forcina
    C Oltolini
    S Piemontese
    P Scarpellini
    S Marktel
    A Assanelli
    M Carrabba
    L Vago
    C Corti
    M Bernardi
    J Peccatori
    F Ciceri
    Bone Marrow Transplantation, 2016, 51 : 1022 - 1024
  • [42] Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients
    E Lengliné
    S Chevret
    A-S Moreau
    F Pène
    F Blot
    J-H Bourhis
    A Buzyn
    B Schlemmer
    G Socié
    E Azoulay
    Bone Marrow Transplantation, 2015, 50 : 840 - 845
  • [43] Red Cell Alloimmunization Rates in Allogeneic Hematopoietic Stem Cell Transplant Recipients
    Prokopchuk-Gauk, Oksana
    Prokopishyn, Nicole L.
    McCarthy, Joanna
    Shabani-Rad, Meer-Taher
    BLOOD, 2016, 128 (22)
  • [44] CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality
    Eberhardt, Kirsten Alexandra
    Jung, Verena
    Knops, Elena
    Heger, Eva
    Wirtz, Maike
    Steger, Gertrud
    Kaiser, Rolf
    Affeldt, Patrick
    Holtick, Udo
    Klein, Florian
    Scheid, Christof
    Di Cristanziano, Veronica
    BONE MARROW TRANSPLANTATION, 2023, 58 (06) : 639 - 646
  • [45] CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality
    Kirsten Alexandra Eberhardt
    Verena Jung
    Elena Knops
    Eva Heger
    Maike Wirtz
    Gertrud Steger
    Rolf Kaiser
    Patrick Affeldt
    Udo Holtick
    Florian Klein
    Christof Scheid
    Veronica Di Cristanziano
    Bone Marrow Transplantation, 2023, 58 : 639 - 646
  • [46] CMV seropositive donor selection for CMV seropositive stem cell transplant recipients reduces CMV reactivation frequency and duration
    Cekauskiene, R.
    Maciutaite, E.
    Lizaitis, M.
    Simutiene, L.
    Trociukas, I.
    Griskevicius, L.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S178 - S178
  • [47] Immune monitoring with iTAg and Oχιρχ; MHC tetramers:: Prediction of recurrent CMV reactivation in allogeneic stem cell transplant recipients.
    Gratama, JW
    Brooimans, R
    Lowenberg, B
    Sullivan, L
    Gasior, G
    Boyce, C
    Southwick, P
    Cornelissen, J
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2004, 62B (01): : 63 - 63
  • [48] Cytomegalovirus (CMV) gB3 Genotype Is Associated with Acute Gvhd and CMV Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients (HSCT)
    Dieamant, Debora de Campos
    Alves Bonon, Sandra Helena
    Aranha, Francisco J. P.
    Duarte, Gislaine O.
    Fernandes, Virginio C. O.
    De Souza, Carmino Antonio
    Botelho Costa, Sandra Cecilia
    Vigorito, Afonso Celso
    BLOOD, 2011, 118 (21) : 854 - 855
  • [49] Cytomegalovirus Reactivation in Hematopoietic Stem Cell Transplant Recipients in High Endemic Population
    Farhan, Muhammad
    Chaudhry, Qamar Un Nisa
    Mahmood, Syed Kamran
    Ghafoor, Tariq
    Iftikhar, Raheel
    Shahbaz, Nighat
    Khan, Mehreen Ali
    Khattak, Tariq
    Shamshad, Ghassan
    Rehman, Jahanzeb
    Ahmed, Parvez
    BLOOD, 2020, 136
  • [50] Risk Factors for CMV Reactivation and Disease Among Hematopoietic Stem Cell Transplant Recipients Defining the Target Population for Letermovir Prophylaxis
    Ngyuen, Thao
    Kaivers, Jennifer
    Adams, Ortwin
    Lubke, Nadine
    Schroeder, Thomas
    Rautenberg, Christina
    Baermann, Ben-Niklas
    Ulrych, Thomas
    Haas, Rainer
    Timm, Joerg
    Kondakci, Mustafa
    Kobbe, Guido
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 497 - 498
12345